Introduction
Methods
Results
Patient characteristics
Variables | Number of patients |
---|---|
Gender | |
Female | 5(6) |
Median age (range) | 52 (33–52) |
Clinical manifestations | |
Dyspnea | 6 |
NYHA class | |
I, II | 2 |
III, IV | 4 |
Chest pain | 2 |
Syncope | 1 |
hemoptysis | 1 |
Constitutional symptoms | |
Fever | 4 |
Fatigue | 5 |
Weight loss | 3 |
Preoperative workup | |
TTE | 6 |
CTPA | 6 |
MRI | 5 |
Pulmonary angiography | 5 |
PET/CT | 4 |
Biopsy | 1 |
Radiologic investments
Surgical techniques
Patient | Cardiopulmonary bypass time (min) | Cross-clamping time (min) | DHCA | |||||
---|---|---|---|---|---|---|---|---|
Temperature (℃) | Circulatory arrest | Circulatory arrest time (min) | ||||||
Tympanum | Anus | Urocyst | Frequency | Time (min) | ||||
1 | 321 | 136 | 18.6 | 20.5 | 20.5 | 3 | 20 + 20 + 4′40 | 44′40 |
2 | 235 | 135 | 15.7 | 18.4 | 18.6 | 2 | 15′30 + 8′40 | 24′10 |
3 | 403 | 196 | 16.2 | 19.8 | 19.3 | 4 | 18′50 + 20 + 6′56 + 8′04 | 53′51 |
4 | 330 | 173 | 18 | 19.8 | 19.8 | 4 | 20 + 20′10 + 20 + 20′10 | 80′20 |
5 | 222 | 96 | 17 | 20.5 | 19.6 | 2 | 13′36 + 4′20 | 17′56 |
6 | 346 | 150 | 18 | 19.8 | 19.8 | 4 | 20 + 10′29 + 20 + 7′20 | 57′49 |
Pathological results
Clinical results
Patient | Gender/age | Misdiagnosis/month | Surgicacl type | Tumor location | PAP(mmHg) | Fast frozen section | Histologic type | Chemotherapy | Recurrence | Survival (month) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Pre-operation | Post-operation | ||||||||||
1 | F/39 | CTEPH/7 | PEA | MPA + BPA | 55 | 30 | − | Pleomorphic fascicular sarcoma with focal myogenic differentiation | A + I | None | 28 (alive) |
2 | F/52 | CTEPH/21 | PEA | MPA + LPA | 44 | 37 | + | Pleomorphic fascicular sarcoma with focal myogenic differentiation | None | Right upper lobe lung | 20(alive) |
3 | M/54 | PE/4 | PEA | MPA + BPA | 40 | 35 | − | Leimyocarcoma | None | None | 15 (alive) |
4 | F/49 | CTEPH/9 | PV resection + PEA | MPA + BPA + PV | 60 | 39 | − | Sarcomsa with osterosarcomatous differentiation | A + I | None | 11(alive) |
5 | F/54 | − | PEA | MPA + RPA | 55 | 38 | − | Fascicular sarcoma | A + I | None | 11 (alive) |
6 | F/33 | − | PEA | MPA + LPA | 40 | 33 | − | Sarcoma with chondrosarcomatoue differentiatiion | A + I | None | 7 (alive) |
Discussion
Radiologic investigations
Surgical treatment of PAS
Surgery strategy
Pneumonectomy
PEA
PEA combined with pneumonectomy
DHCA
Pulmonary valve involvement
Adjuvant therapy
Study | Neo/adjuvant | None | P-value | ||
---|---|---|---|---|---|
n | total survival time (month) | n | Total survival time (month) | ||
Anderson et al. [20] | 5 | 51 | 1 | 5 | |
Mayer et al. [19] | 6 | 162 | 1 | 9 | |
Kim et al. [4] | 5 | 104 | 4 | 50 | |
Blackmon et al. [15] | 8 | 284 | 0 | - | |
Gan et al. [14] | 7 | 166 | 2 | 46 | |
Deng et al. [7] | 8 | 99 | 3 | 58 | |
Huo et al. [18] | 6 | 176 | 5 | 50 | |
Average | 45 | 23 ± 18 | 16 | 14 ± 13 | 0.06 |